伴肺动脉高压的系统性红斑狼疮患者肝损伤1例报告

李彦霖; 王一川; 吴剑华; 贾佩; 汪瑶; 樊万虎; 刘正稳; 罗静; 张松林; 刘小静

doi:10.3969/j.issn.1001-5256.2022.02.031

伴肺动脉高压的系统性红斑狼疮患者肝损伤1例报告

DOI: 10.3969/j.issn.1001-5256.2022.02.031

李彦霖^1a,
王一川²,
吴剑华²,
贾佩³,
汪瑶^1b,
樊万虎^1b,
刘正稳^1b,
罗静^1c,
张松林^1d,
刘小静^1b, ,

1a.
西安交通大学第一附属医院肿瘤内科，西安 710061
1b.
西安交通大学第一附属医院感染科，西安 710061
1c.
西安交通大学第一附属医院风湿免疫科，西安 710061
1d.
西安交通大学第一附属医院结构性心脏病科，西安 710061
2.
西安交通大学医学部，西安 710061
3.
蒲城县医院感染科，陕西渭南 715500

基金项目:

国家艾滋病和病毒性肝炎等重大传染病防治科技专项课题 (2018ZX10302206)

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：李彦霖、王一川、吴剑华负责课题设计，资料分析，撰写论文；贾佩、汪瑶参与收集数据，修改论文；樊万虎、刘正稳、罗静、张松林、刘小静负责拟定写作思路，指导撰写文章并最后定稿。

详细信息

通信作者:
刘小静，xiaojing406@163.com

计量
- 文章访问数: 497
- HTML全文浏览量: 94
- PDF下载量: 30
- 被引次数: 0
出版历程
- 收稿日期: 2021-05-12
- 录用日期: 2021-08-09
- 出版日期: 2022-02-20

Liver injury in patients with systemic lupus erythematosus with pulmonary hypertension: A case report

1a.
Department of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
1b.
Department of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
1c.
Department of Rheumatology and Immunology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
1d.
Department of Structural Cardiology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
2.
Xi'an Jiaotong University Health Science Center, Xi'an 710061, China
3.
Department of Infectious Diseases, Pucheng County Hospital, Weinan, Shaanxi 715500, China

Research funding:

National Science and Technology Projects (2018ZX10302206)

More Information

Corresponding author: LIU Xiaojing, xiaojing406@163.com

摘要

- 高血压, 肺性 /
- 红斑狼疮, 系统性 /
- 化学性与药物性肝损伤
- Hypertension, Pulmonary /
- Lupus Erythematosus, Systemic /
- Chemical and Drug Induced Liver Injury

HTML全文

图 1 肺动脉造影检查结果

注：a，右肺动脉主干扩张(箭头)，肺动脉段突出(三角)；b，远端肺血管迂曲扩张(箭头)。

下载: 全尺寸图片幻灯片

参考文献(21)

[1]	KIRIAKIDOU M, CHING CL. Systemic lupus erythematosus[J]. Ann Intern Med, 2020, 172(11): ITC81-ITC96. DOI: 10.7326/AITC202006020.
[2]	Chinese Rheumatology Association, National Clinical Research Center for Dermatologic and Immunologic Diseases, Chinese Systemic Lupus Erythematosus Treatment and Research Group. 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus[J]. Chin J Intern Med, 2020, 59(3): 172-185. DOI: 10.3760/cma.j.issn.0578-1426.2020.03.002. 中华医学会风湿病学分会, 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志, 2020, 59(3): 172-185. DOI: 10.3760/cma.j.issn.0578-1426.2020.03.002.
[3]	GALIÈ N, CHANNICK RN, FRANTZ RP, et al. Risk stratification and medical therapy of pulmonary arterial hypertension[J]. Eur Respir J, 2019, 53(1): 1801889. DOI: 10.1183/13993003.01889-2018.
[4]	SONG ZR, ZHANG WR, CAO X, et al. Literature case analysis of liver injury caused by bosentan[J]. ADRJ, 2020, 22(12): 683-688. DOI: 10.3760/cma.j.cn114015-20200511-00520. 宋兆芮, 张文锐, 曹雪, 等. 波生坦致肝损伤文献病例分析[J]. 药物不良反应杂志, 2020, 22(12): 683-688. DOI: 10.3760/cma.j.cn114015-20200511-00520.
[5]	WEI A, GU Z, LI J, et al. Clinical adverse effects of endothelin receptor antagonists: Insights from the meta-analysis of 4894 patients from 24 randomized double-blind placebo-controlled clinical trials[J]. J Am Heart Assoc, 2016, 5(11): e003896. DOI: 10.1161/JAHA.116.003896.
[6]	GALIÈ N, HUMBERT M, VACHIERY JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)[J]. Eur Respir J, 2015, 46(4): 903-975. DOI: 10.1183/13993003.01032-2015.
[7]	HACHULLA E, JAIS X, CINQUETTI G, et al. Pulmonary arterial hypertension associated with systemic lupus erythematosus: Results from the french pulmonary hypertension registry[J]. Chest, 2018, 153(1): 143-151. DOI: 10.1016/j.chest.2017.08.014.
[8]	WANG MJ, YANG YX, JI QW. Connective tissue disease in pulmonary arterial hypertension[J]. Chin J New Clin Med, 2020, 13(9): 874-877. DOI: 10.3969/j.issn.1674-3806.2020.09.06. 王孟杰, 杨映霞, 吉庆伟. 肺动脉高压之结缔组织疾病[J]. 中国临床新医学, 2020, 13(9): 874-877. DOI: 10.3969/j.issn.1674-3806.2020.09.06.
[9]	CHEN HA, HSU TC, YANG SC, et al. Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: A nationwide cohort study[J]. Arthritis Res Ther, 2019, 21(1): 82. DOI: 10.1186/s13075-019-1868-0.
[10]	ARINGER M, COSTENBADER K, DAIKH D, et al. 2019 European league against Rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus[J]. Arthritis Rheumatol, 2019, 71(9): 1400-1412. DOI: 10.1002/art.40930.
[11]	GEBRESELASSIE A, ADULI F, HOWELL CD. Rheumatologic diseases and the liver[J]. Clin Liver Dis, 2019, 23(2): 247-261. DOI: 10.1016/j.cld.2018.12.007.
[12]	TAKAHASHI A, ABE K, SAITO R, et al. Liver dysfunction in patients with systemic lupus erythematosus[J]. Intern Med, 2013, 52(13): 1461-1465. DOI: 10.2169/internalmedicine.52.9458.
[13]	AFZAL W, HAGHI M, HASNI SA, et al. Lupus hepatitis, more than just elevated liver enzymes[J]. Scand J Rheumatol, 2020, 49(6): 427-433. DOI: 10.1080/03009742.2020.1744712.
[14]	MIELI-VERGANI G, VERGANI D, CZAJA AJ, et al. Autoimmune hepatitis[J]. Nat Rev Dis Primers, 2018, 4: 18017. DOI: 10.1038/nrdp.2018.17.
[15]	ADIGA A, NUGENT K. Lupus hepatitis and autoimmune hepatitis (lupoid hepatitis)[J]. Am J Med Sci, 2017, 353(4): 329-335. DOI: 10.1016/j.amjms.2016.10.014.
[16]	ZHANG MY, HAN L, SUN Y, et al. Research advances in clinical treatment of adult autoimmune hepatitis[J]. J Clin Hepatol, 2021, 37(6): 1459-1465. DOI: 10.3969/j.issn.1001-5256.2021.06.050. 张明月, 韩琳, 孙颖, 等. 成人自身免疫性肝炎临床治疗进展[J]. 临床肝胆病杂志, 2021, 37(6): 1459-1465. DOI: 10.3969/j.issn.1001-5256.2021.06.050.
[17]	ALVES S C, FASANO S, ISENBERG DA. Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review[J]. Lupus, 2016, 25(14): 1509-1519. DOI: 10.1177/0961203316655210.
[18]	EFE C, PURNAK T, OZASLAN E. Systemic lupus erythematosus and autoimmune hepatitis[J]. Rheumatol Int, 2011, 31(3): 419. DOI: 10.1007/s00296-010-1581-4.
[19]	XU Y. A comparison of autoimmune hepatitis and systemic lupus erythematosus-associated hepatitis[J]. Chin J Gastroenterol Hepatol, 2009, 18(4): 366-368. DOI: 10.3969/j.issn.1006-5709.2009.04.027. 徐芸. 自身免疫性肝炎与系统性红斑狼疮性肝损伤临床特征对比[J]. 胃肠病学和肝病学杂志, 2009, 18(4): 366-368. DOI: 10.3969/j.issn.1006-5709.2009.04.027.
[20]	National Data Center for Rheumatic Disease, Chinese Research and Cooperation Group for Systemic Lupus Erythe. Diagnosis and treatment consensus on systemic lupus erythematosus associated pulmonary hypertension in Chinese adults[J]. Chin J Intern Med, 2015, 54(1): 81-86. DOI: 10.3760/cma.j.issn.0578-1426.2015.01.024. 国家风湿病数据中心, 中国系统性红斑狼疮研究协作组. 中国成人系统性红斑狼疮相关肺动脉高压诊治共识[J]. 中华内科杂志, 2015, 54(1): 81-86. DOI: 10.3760/cma.j.issn.0578-1426.2015.01.024.
[21]	KAESTNER M, SCHRANZ D, WARNECKE G, et al. Pulmonary hypertension in the intensive care unit. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK[J]. Heart, 2016, 102(Suppl 2): i57-i66. DOI: 10.1136/heartjnl-2015-307774.